endometrial cancer

You have access
Tissue Expression and Plasma Soluble PD-L1 Levels in Patients With Endometrial Cancer
EMMANUEL KONTOMANOLIS, ANTONIOS KOUTRAS, ACHILLEAS G. MITRAKAS, GRIGORIOS TRYPSIANIS, KONSTANTINOS NIKOLETTOS, PANAGIOTIS TSIKOURAS, NIKOLAOS NIKOLETTOS, ALEXANDRA GIATROMANOLAKI and MICHAEL KOUKOURAKIS

Anticancer Research December 2024, 44 (12) 5525-5530; DOI: https://doi.org/10.21873/anticanres.17378
Open Access
Hypoxia-induced Factor-1α and its Role in Endometrial Cancer
BEATA SMOLARZ, HONORATA ŁUKASIEWICZ, DARIUSZ SAMULAK, RADOSŁAW KOŁACIŃSKI, SARA LANGNER, MARIANNA MAKOWSKA and HANNA ROMANOWICZ

Anticancer Research September 2024, 44 (9) 3697-3712; DOI: https://doi.org/10.21873/anticanres.17195
Open Access
Integration of the Molecular Classification of Endometrial Carcinoma to Select Patients for Fertility Sparing Strategies
MOHAMED AMINE BANI, AMANDINE MAULARD, PHILIPPE MORICE, CYRUS CHARGARI and CATHERINE GENESTIE

Anticancer Research February 2024, 44 (2) 445-452; DOI: https://doi.org/10.21873/anticanres.16832
You have access
E2F7/RAD51AP1 Axis Inhibits Endometrial Cancer Sensitivity to 5-FU via the Fatty Acid Metabolic Pathway
XIAOYAN HUANG, ZAIXIN WU, CHUNHONG XIAO and XI CHEN

Anticancer Research November 2023, 43 (11) 4905-4914; DOI: https://doi.org/10.21873/anticanres.16688
You have access
HPV16 E6 Gene Transcripts in Primary Type II Endometrial Carcinomas
WIKTOR SZEWCZUK, OKSANA SZEWCZUK, KRZYSZTOF CZAJKOWSKI, MACIEJ WAŁĘDZIAK, BARBARA GORNICKA, TOMASZ ILCZUK, WERONIKA KAWECKA and ANDRZEJ SEMCZUK

Anticancer Research November 2023, 43 (11) 5083-5088; DOI: https://doi.org/10.21873/anticanres.16708
You have access
Medroxyprogesterone as the Initial Systemic Treatment of Recurrent Endometrial Cancer: A Single Institutional Study
MAIKO KOROSUE, KOHEI NAKAGAWA, KANAKO YOSHIYASU, SACHIYO NARITA, ROZE ISONO-TANIGUCHI, YUMI TAKIMOTO, TOMOKO UEDA, MAYA OMOTE, YU WAKIMOTO, HIROSHI TSUBAMOTO, SEIICHI HIROTA and HIROAKI SHIBAHARA

Anticancer Research August 2023, 43 (8) 3693-3699; DOI: https://doi.org/10.21873/anticanres.16552
You have access
Acquired AKT-inhibitor Resistance Is Mediated by ATP-binding Cassette Transporters in Endometrial Carcinoma
SHOJI TAKAGI, TAKAFUMI ONISHI, TSUYOSHI TAKASHIMA, KAZUKI SHIBAHARA and MICHIHIRO MORI

Anticancer Research June 2023, 43 (6) 2501-2507; DOI: https://doi.org/10.21873/anticanres.16417
You have access
Treatment of Mediastinal Endometrial Carcinoma Developed from Extragenital Endometriosis and Simultaneous Rectal Adenocarcinoma in a 55-year-old Woman
KLARA DORMAN, DANMEI ZHANG, WOLFGANG G. KUNZ, MARTIN ANGELE, JENS NEUMANN, ALEXANDER BURGES, MICHAEL VON BERGWELT-BAILDON, VOLKER HEINEMANN, STEFAN BOECK and CLEMENS GIESSEN-JUNG

Anticancer Research April 2023, 43 (4) 1857-1861; DOI: https://doi.org/10.21873/anticanres.16340
You have access
Lymph-vascular Space Involvement and/or p53 Overexpression Correlated With the Clinical Outcome of Early-stage Endometrial Cancer Patients Treated With Adjuvant Vaginal Brachytherapy
CONCETTA LALISCIA, ANGIOLO GADDUCCI, NATALINA COCCIA, ROBERTO MATTIONI, TAIUSHA FUENTES, MARTA CARETTO, SABINA PISTOLESI, PAOLA PUCCINI, FRANCO PERRONE, RICCARDO MORGANTI and FABIOLA PAIAR

Anticancer Research January 2023, 43 (1) 149-156; DOI: https://doi.org/10.21873/anticanres.16144
You have access
Molecular Characteristics of Metastatic Lesions Have Superior Prognostic Impact on Endometrial Cancer
KAZUHIRO OKAMOTO, KEIICHIRO NAKAMURA, JUNKO HARAGA and HISASHI MASUYAMA

Anticancer Research September 2022, 42 (9) 4535-4543; DOI: https://doi.org/10.21873/anticanres.15956

Main menu

User menu

Search

endometrial cancer

Pages